vs

Side-by-side financial comparison of Global Business Travel Group, Inc. (GBTG) and ResMed (RMD). Click either name above to swap in a different company.

ResMed is the larger business by last-quarter revenue ($1.4B vs $792.0M, roughly 1.8× Global Business Travel Group, Inc.). ResMed runs the higher net margin — 27.6% vs 10.5%, a 17.1% gap on every dollar of revenue. On growth, Global Business Travel Group, Inc. posted the faster year-over-year revenue change (34.0% vs 11.0%). Over the past eight quarters, Global Business Travel Group, Inc.'s revenue compounded faster (13.9% CAGR vs 7.9%).

A travel management company (TMC) is a travel agency which manages organizations' corporate or business travel programs. Such companies will often provide an end-user online booking tool, mobile application, program management, and consulting teams, executive travel services, meetings and events support, reporting functionality, duty of care, and more. Non-Profit travel management companies also provide services to manage complex visa requirements, pre-trip medical needs, remote area travel, ...

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

GBTG vs RMD — Head-to-Head

Bigger by revenue
RMD
RMD
1.8× larger
RMD
$1.4B
$792.0M
GBTG
Growing faster (revenue YoY)
GBTG
GBTG
+23.0% gap
GBTG
34.0%
11.0%
RMD
Higher net margin
RMD
RMD
17.1% more per $
RMD
27.6%
10.5%
GBTG
Faster 2-yr revenue CAGR
GBTG
GBTG
Annualised
GBTG
13.9%
7.9%
RMD

Income Statement — Q4 FY2025 vs Q4 FY2026

Metric
GBTG
GBTG
RMD
RMD
Revenue
$792.0M
$1.4B
Net Profit
$83.0M
$392.6M
Gross Margin
61.8%
Operating Margin
3.7%
34.6%
Net Margin
10.5%
27.6%
Revenue YoY
34.0%
11.0%
Net Profit YoY
692.9%
13.9%
EPS (diluted)
$0.16
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GBTG
GBTG
RMD
RMD
Q2 26
$1.4B
Q4 25
$792.0M
$1.4B
Q3 25
$674.0M
$1.3B
Q2 25
$631.0M
$1.3B
Q1 25
$621.0M
$1.3B
Q4 24
$591.0M
$1.3B
Q3 24
$597.0M
$1.2B
Q2 24
$625.0M
$1.2B
Net Profit
GBTG
GBTG
RMD
RMD
Q2 26
$392.6M
Q4 25
$83.0M
$392.6M
Q3 25
$-62.0M
$348.5M
Q2 25
$15.0M
$379.7M
Q1 25
$75.0M
$365.0M
Q4 24
$-14.0M
$344.6M
Q3 24
$-128.0M
$311.4M
Q2 24
$27.0M
$292.2M
Gross Margin
GBTG
GBTG
RMD
RMD
Q2 26
61.8%
Q4 25
61.8%
Q3 25
61.5%
Q2 25
60.8%
Q1 25
59.3%
Q4 24
58.6%
Q3 24
58.6%
Q2 24
58.5%
Operating Margin
GBTG
GBTG
RMD
RMD
Q2 26
34.6%
Q4 25
3.7%
34.6%
Q3 25
1.8%
33.4%
Q2 25
5.4%
33.7%
Q1 25
8.9%
33.0%
Q4 24
5.1%
32.5%
Q3 24
4.5%
31.6%
Q2 24
6.7%
31.2%
Net Margin
GBTG
GBTG
RMD
RMD
Q2 26
27.6%
Q4 25
10.5%
27.6%
Q3 25
-9.2%
26.1%
Q2 25
2.4%
28.2%
Q1 25
12.1%
28.3%
Q4 24
-2.4%
26.9%
Q3 24
-21.4%
25.4%
Q2 24
4.3%
23.9%
EPS (diluted)
GBTG
GBTG
RMD
RMD
Q2 26
$2.68
Q4 25
$0.16
$2.68
Q3 25
$-0.13
$2.37
Q2 25
$0.03
$2.58
Q1 25
$0.16
$2.48
Q4 24
$-0.04
$2.34
Q3 24
$-0.28
$2.11
Q2 24
$0.06
$1.97

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GBTG
GBTG
RMD
RMD
Cash + ST InvestmentsLiquidity on hand
$434.0M
$1.4B
Total DebtLower is stronger
$1.4B
$663.8M
Stockholders' EquityBook value
$1.6B
$6.3B
Total Assets
$4.9B
$8.5B
Debt / EquityLower = less leverage
0.88×
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GBTG
GBTG
RMD
RMD
Q2 26
$1.4B
Q4 25
$434.0M
$1.4B
Q3 25
$427.0M
$1.4B
Q2 25
$601.0M
$1.2B
Q1 25
$552.0M
$932.7M
Q4 24
$536.0M
$521.9M
Q3 24
$524.0M
$426.4M
Q2 24
$515.0M
$238.4M
Total Debt
GBTG
GBTG
RMD
RMD
Q2 26
$663.8M
Q4 25
$1.4B
$403.9M
Q3 25
$1.4B
$408.7M
Q2 25
$1.4B
$658.4M
Q1 25
$1.4B
$663.1M
Q4 24
$1.4B
$662.9M
Q3 24
$1.4B
$667.6M
Q2 24
$697.3M
Stockholders' Equity
GBTG
GBTG
RMD
RMD
Q2 26
$6.3B
Q4 25
$1.6B
$6.3B
Q3 25
$1.5B
$6.1B
Q2 25
$1.2B
$6.0B
Q1 25
$1.1B
$5.5B
Q4 24
$1.1B
$5.3B
Q3 24
$1.1B
$5.2B
Q2 24
$1.2B
$4.9B
Total Assets
GBTG
GBTG
RMD
RMD
Q2 26
$8.5B
Q4 25
$4.9B
$8.5B
Q3 25
$4.8B
$8.3B
Q2 25
$3.9B
$8.2B
Q1 25
$3.8B
$7.6B
Q4 24
$3.6B
$7.1B
Q3 24
$3.8B
$7.2B
Q2 24
$3.8B
$6.9B
Debt / Equity
GBTG
GBTG
RMD
RMD
Q2 26
0.11×
Q4 25
0.88×
0.06×
Q3 25
0.91×
0.07×
Q2 25
1.15×
0.11×
Q1 25
1.23×
0.12×
Q4 24
1.32×
0.13×
Q3 24
1.26×
0.13×
Q2 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GBTG
GBTG
RMD
RMD
Operating Cash FlowLast quarter
$52.0M
Free Cash FlowOCF − Capex
$13.0M
FCF MarginFCF / Revenue
1.6%
Capex IntensityCapex / Revenue
4.9%
Cash ConversionOCF / Net Profit
0.63×
TTM Free Cash FlowTrailing 4 quarters
$104.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GBTG
GBTG
RMD
RMD
Q2 26
Q4 25
$52.0M
$339.7M
Q3 25
$71.0M
$457.3M
Q2 25
$57.0M
$538.8M
Q1 25
$53.0M
$578.7M
Q4 24
$65.0M
$308.6M
Q3 24
$85.0M
$325.5M
Q2 24
$73.0M
$440.1M
Free Cash Flow
GBTG
GBTG
RMD
RMD
Q2 26
Q4 25
$13.0M
$311.2M
Q3 25
$38.0M
$414.4M
Q2 25
$27.0M
$508.2M
Q1 25
$26.0M
$557.9M
Q4 24
$33.0M
$288.0M
Q3 24
$59.0M
$307.7M
Q2 24
$49.0M
$415.2M
FCF Margin
GBTG
GBTG
RMD
RMD
Q2 26
Q4 25
1.6%
21.9%
Q3 25
5.6%
31.0%
Q2 25
4.3%
37.7%
Q1 25
4.2%
43.2%
Q4 24
5.6%
22.5%
Q3 24
9.9%
25.1%
Q2 24
7.8%
33.9%
Capex Intensity
GBTG
GBTG
RMD
RMD
Q2 26
Q4 25
4.9%
2.0%
Q3 25
4.9%
3.2%
Q2 25
4.8%
2.3%
Q1 25
4.3%
1.6%
Q4 24
5.4%
1.6%
Q3 24
4.4%
1.5%
Q2 24
3.8%
2.0%
Cash Conversion
GBTG
GBTG
RMD
RMD
Q2 26
Q4 25
0.63×
0.87×
Q3 25
1.31×
Q2 25
3.80×
1.42×
Q1 25
0.71×
1.59×
Q4 24
0.90×
Q3 24
1.05×
Q2 24
2.70×
1.51×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GBTG
GBTG

Travel$620.0M78%
Other$172.0M22%

RMD
RMD

Segment breakdown not available.

Related Comparisons